Trial Profile
Pazopanib in metastatic soft tissue sarcoma experience from a tertiary cancer centre in India
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jun 2018
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 25 Jun 2018 New trial record